Annual SGA
$11.33 M
-$4.25 M-27.27%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual SGA is $11.33 million, with the most recent change of -$4.25 million (-27.27%) on December 1, 2023.
- During the last 3 years, BRTX annual SGA has risen by +$9.38 million (+480.47%).
- BRTX annual SGA is now -55.78% below its all-time high of $25.62 million, reached on December 31, 2021.
Performance
BRTX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.18 M
-$76.90 K-6.11%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly SGA is $1.18 million, with the most recent change of -$76.90 thousand (-6.11%) on September 1, 2024.
- Over the past year, BRTX quarterly SGA has dropped by -$1.14 million (-49.15%).
- BRTX quarterly SGA is now -92.07% below its all-time high of $14.91 million, reached on March 31, 2021.
Performance
BRTX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$602.62 M
+$10.19 M+1.66%
September 1, 2024
Summary
- As of February 7, 2025, BRTX TTM SGA is -$602.62 million, with the most recent change of +$10.19 million (+1.66%) on September 1, 2024.
- Over the past year, BRTX TTM SGA has dropped by -$615.81 million (-4667.28%).
- BRTX TTM SGA is now -17364.08% below its all-time high of -$3.45 million.
Performance
BRTX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
BRTX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.3% | -49.1% | -4667.3% |
| 3 y3 years | +480.5% | -69.3% | -2451.7% |
| 5 y5 years | +81.4% | -69.3% | -2451.7% |
BRTX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -55.8% | at low | -74.2% | at low | -30.2% | +4.4% |
| 5 y | 5-year | -55.8% | +480.5% | -92.1% | +439.9% | -104.0% | +4.4% |
| alltime | all time | -55.8% | +480.5% | -92.1% | +439.9% | <-9999.0% | +4.4% |
BioRestorative Therapies Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.18 M(-6.1%) | $7.68 M(-13.0%) |
| Jun 2024 | - | $1.26 M(-59.2%) | $8.82 M(-10.4%) |
| Mar 2024 | - | $3.09 M(+43.5%) | $9.84 M(-13.2%) |
| Dec 2023 | $11.33 M(-27.3%) | $2.15 M(-7.5%) | $11.33 M(-14.1%) |
| Sep 2023 | - | $2.33 M(+2.1%) | $13.19 M(-9.1%) |
| Jun 2023 | - | $2.28 M(-50.2%) | $14.52 M(-8.5%) |
| Mar 2023 | - | $4.58 M(+14.1%) | $15.86 M(+1.8%) |
| Dec 2022 | $15.58 M(-39.2%) | $4.01 M(+9.9%) | $15.58 M(+1.1%) |
| Sep 2022 | - | $3.65 M(+0.7%) | $15.42 M(+1.2%) |
| Jun 2022 | - | $3.62 M(-15.6%) | $15.23 M(+1.4%) |
| Mar 2022 | - | $4.29 M(+11.6%) | $15.01 M(-41.4%) |
| Dec 2021 | $25.62 M(+1212.6%) | $3.85 M(+11.3%) | $25.62 M(+14.0%) |
| Sep 2021 | - | $3.46 M(+1.5%) | $22.47 M(+15.9%) |
| Jun 2021 | - | $3.41 M(-77.1%) | $19.38 M(+19.7%) |
| Mar 2021 | - | $14.91 M(+2049.3%) | $16.19 M(+732.4%) |
| Dec 2020 | $1.95 M(-71.5%) | $693.60 K(+85.4%) | $1.95 M(-35.7%) |
| Sep 2020 | - | $374.20 K(+70.9%) | $3.02 M(-26.2%) |
| Jun 2020 | - | $219.00 K(-66.8%) | $4.10 M(-26.8%) |
| Mar 2020 | - | $658.70 K(-62.8%) | $5.60 M(-18.2%) |
| Dec 2019 | $6.84 M(+9.5%) | $1.77 M(+22.5%) | $6.84 M(-0.9%) |
| Sep 2019 | - | $1.45 M(-15.8%) | $6.90 M(+9.4%) |
| Jun 2019 | - | $1.72 M(-9.7%) | $6.31 M(+0.1%) |
| Mar 2019 | - | $1.90 M(+3.9%) | $6.31 M(+1.0%) |
| Dec 2018 | $6.25 M(-0.9%) | $1.83 M(+113.6%) | $6.25 M(+8.1%) |
| Sep 2018 | - | $857.20 K(-50.0%) | $5.78 M(-6.7%) |
| Jun 2018 | - | $1.71 M(-7.0%) | $6.19 M(-4.1%) |
| Mar 2018 | - | $1.84 M(+35.0%) | $6.46 M(+2.4%) |
| Dec 2017 | $6.30 M | $1.37 M(+7.6%) | $6.30 M(+4.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $1.27 M(-35.9%) | $6.05 M(+3.5%) |
| Jun 2017 | - | $1.98 M(+17.0%) | $5.85 M(+7.9%) |
| Mar 2017 | - | $1.69 M(+51.9%) | $5.42 M(+9.7%) |
| Dec 2016 | $4.94 M(-9.1%) | $1.11 M(+4.6%) | $4.94 M(-19.4%) |
| Sep 2016 | - | $1.06 M(-31.4%) | $6.13 M(+2.4%) |
| Jun 2016 | - | $1.55 M(+28.1%) | $5.98 M(+12.5%) |
| Mar 2016 | - | $1.21 M(-47.4%) | $5.32 M(-2.2%) |
| Dec 2015 | $5.43 M(+47.1%) | $2.30 M(+150.3%) | $5.43 M(+33.5%) |
| Sep 2015 | - | $919.50 K(+4.0%) | $4.07 M(+5.7%) |
| Jun 2015 | - | $884.40 K(-33.4%) | $3.85 M(-5.8%) |
| Mar 2015 | - | $1.33 M(+41.5%) | $4.09 M(+10.6%) |
| Dec 2014 | $3.69 M(+16.9%) | $938.20 K(+34.2%) | $3.69 M(+3.8%) |
| Sep 2014 | - | $699.10 K(-37.7%) | $3.56 M(-0.4%) |
| Jun 2014 | - | $1.12 M(+20.0%) | $3.57 M(+11.9%) |
| Mar 2014 | - | $935.00 K(+16.3%) | $3.19 M(+1.1%) |
| Dec 2013 | $3.16 M(-34.6%) | $804.00 K(+12.6%) | $3.16 M(-15.8%) |
| Sep 2013 | - | $714.20 K(-3.7%) | $3.75 M(-5.5%) |
| Jun 2013 | - | $741.40 K(-17.6%) | $3.97 M(-11.0%) |
| Mar 2013 | - | $900.10 K(-35.5%) | $4.46 M(-7.7%) |
| Dec 2012 | $4.83 M(+36.4%) | $1.40 M(+49.5%) | $4.83 M(+18.8%) |
| Sep 2012 | - | $933.80 K(-24.1%) | $4.07 M(+2.0%) |
| Jun 2012 | - | $1.23 M(-3.2%) | $3.98 M(+5.1%) |
| Mar 2012 | - | $1.27 M(+101.3%) | $3.79 M(+7.1%) |
| Dec 2011 | $3.54 M(+72.0%) | $631.20 K(-26.0%) | $3.54 M(-13.3%) |
| Sep 2011 | - | $853.00 K(-17.8%) | $4.09 M(+13.4%) |
| Jun 2011 | - | $1.04 M(+2.0%) | $3.60 M(+40.5%) |
| Mar 2011 | - | $1.02 M(-13.5%) | $2.56 M(+65.8%) |
| Dec 2010 | $2.06 M | $1.18 M(+217.8%) | $1.55 M(+317.8%) |
| Sep 2010 | - | $370.20 K | $370.20 K |
FAQ
- What is BioRestorative Therapies annual SGA?
- What is the all time high annual SGA for BioRestorative Therapies?
- What is BioRestorative Therapies annual SGA year-on-year change?
- What is BioRestorative Therapies quarterly SGA?
- What is the all time high quarterly SGA for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly SGA year-on-year change?
- What is BioRestorative Therapies TTM SGA?
- What is the all time high TTM SGA for BioRestorative Therapies?
- What is BioRestorative Therapies TTM SGA year-on-year change?
What is BioRestorative Therapies annual SGA?
The current annual SGA of BRTX is $11.33 M
What is the all time high annual SGA for BioRestorative Therapies?
BioRestorative Therapies all-time high annual SGA is $25.62 M
What is BioRestorative Therapies annual SGA year-on-year change?
Over the past year, BRTX annual SGA has changed by -$4.25 M (-27.27%)
What is BioRestorative Therapies quarterly SGA?
The current quarterly SGA of BRTX is $1.18 M
What is the all time high quarterly SGA for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly SGA is $14.91 M
What is BioRestorative Therapies quarterly SGA year-on-year change?
Over the past year, BRTX quarterly SGA has changed by -$1.14 M (-49.15%)
What is BioRestorative Therapies TTM SGA?
The current TTM SGA of BRTX is -$602.62 M
What is the all time high TTM SGA for BioRestorative Therapies?
BioRestorative Therapies all-time high TTM SGA is -$3.45 M
What is BioRestorative Therapies TTM SGA year-on-year change?
Over the past year, BRTX TTM SGA has changed by -$615.81 M (-4667.28%)